These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12527166)

  • 1. Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages.
    Salem II; Düzgünes N
    Int J Pharm; 2003 Jan; 250(2):403-14. PubMed ID: 12527166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
    Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):523-7. PubMed ID: 8203849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
    Majumdar S; Flasher D; Friend DS; Nassos P; Yajko D; Hadley WK; Düzgüneş N
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2808-15. PubMed ID: 1482150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
    Tomioka H; Sano C; Sato K; Shimizu T
    Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages.
    Mor N; Heifets L
    Antimicrob Agents Chemother; 1993 Jan; 37(1):111-4. PubMed ID: 8431006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
    Fattorini L; Li B; Piersimoni C; Tortoli E; Xiao Y; Santoro C; Ricci ML; Orefici G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):680-5. PubMed ID: 7793873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of clofazimine-modified cyclodextrin against Mycobacterium avium complex in human macrophages.
    Salem II; Steffan G; Düzgünes N
    Int J Pharm; 2003 Jul; 260(1):105-14. PubMed ID: 12818815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Akaki T; Kawahara S
    Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
    Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H
    J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of potassium tellurite for rapid-drug susceptibility testing of Mycobacterium avium complex.
    Afghani B; Fujiyama D
    J Investig Med; 2001 May; 49(3):292-6. PubMed ID: 11352188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells.
    Sato K; Tomioka H
    J Antimicrob Chemother; 1999 Mar; 43(3):351-7. PubMed ID: 10223590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
    Inderlied CB; Barbara-Burnham L; Wu M; Young LS; Bermudez LE
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1838-43. PubMed ID: 7986017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages.
    Ashtekar D; Düzgünes N; Gangadharam PR
    J Antimicrob Chemother; 1991 Oct; 28(4):615-7. PubMed ID: 1761459
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages.
    Kesavalu L; Goldstein JA; Debs RJ; Düzgünes N; Gangadharam PR
    Tubercle; 1990 Sep; 71(3):215-7. PubMed ID: 2238129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the "RAM" susceptibility testing method for rapid detection of clarithromycin resistance in the Mycobacterium avium complex.
    Flauta V; Osterhout G; Ellis B; Grayson M; Sasser M; Cohen S; Sander M; Dionne K; Carroll K; Parrish N
    Diagn Microbiol Infect Dis; 2010 May; 67(1):47-51. PubMed ID: 20226616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.